Menu
Menu
Glenmark Pharmaceuticals has launched its Travoprost Ophthalmic Solution USP, 0.004%, a generic alternative to Travatan Z, designed to help manage glaucoma and ocular hypertension. This cost-effective, bioequivalent solution offers the same therapeutic benefits, providing patients with an affordable option for controlling intraocular pressure and preventing optic nerve damage.